• Home >
  • Publications >
  • High-Relaxivity Molecular MRI Contrast Agent to Target Gb3-Expressing Cancer Cells

High-Relaxivity Molecular MRI Contrast Agent to Target Gb3-Expressing Cancer Cells

19 Jan 2022Bioconjugate Chemistry

DOI : 10.1021/acs.bioconjchem.1c00531

Authors

Stéphanie Deville-Foillard, Anne Billet, Rose-Marie Dubuisson, Ludger Johannes, Philippe Durand, Frédéric Schmidt, Andreas Volk

Members

LUDGER JOHANNES

Inserm Research Director